By my reckoning the timelines for the PH3 BV Trial should be as...

By my reckoning the timelines for the PH3 BV Trial should be as follows:

- Enrolment completed @ 13/10/16

- 16 week treatment period for the PH3 Trial should have been completed at the very latest 13/02/2017

- 12 week follow up period is still underway and should be completed by 13/05/2017.

NOTE: These timelines are based on the last enrolled patient as per the announcement made on 13/10/2016.

Will there be any announcements made to the market prior to the 12 week follow up period being completed? Should there have been an announcement to the market upon completion of the 16 week Treatment period?